-+ 0.00%
-+ 0.00%
-+ 0.00%

Reyon Pharmaceutical filing shows pledged shares cut to 31.99% from 32.73%

PUBT·10/08/2026 08:36:35
Listen to the news
Reyon Pharmaceutical filing shows pledged shares cut to 31.99% from 32.73%
  • A Reyon Pharmaceutical executive disclosure showed no change in the controlling group’s stake in Ilyon Pharm as of Oct. 8, 2026.
  • Holdings stayed at 10,006,691 shares, unchanged at 53.84%.
  • Shares tied to major contracts fell to 5,946,259 from 6,082,982, reflecting partial termination of stock-backed loan agreements.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reyon Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008000597), on October 08, 2026, and is solely responsible for the information contained therein.